About
Dr. Esther M. Alegria has been a director of STERIS since 2023 and chairs the Compliance and Technology Committee while also serving on the Nominating and Governance Committee. She has more than 25 years of biopharmaceutical experience advancing vaccines and therapeutic drugs from R&D through commercialization, and currently serves as an Executive Consultant and Advisor with The LaSalle Group.
Roles
STERIS plc
Independent Director; Chair of the Compliance and Technology Committee · Current role
2023–present
APIE Therapeutics
Chief Executive Officer (2020-2023) and Chief Innovation Officer (2023-2025); Founder
—
Catalyst Excel & Advance
Founder and Advisor (2016-2020)
—
Biogen, Inc.
Senior Vice President, Global Manufacturing (2005-2015)
—
Banner Pharmacaps, Inc. / Wyeth (R&D Vaccines)
Positions of increasing responsibility
—
External Roles
The LaSalle Group
Executive Consultant and Advisor
—
AVID Bioservices, Inc.
Director (2021-2025)
—
Puerto Rico Science, Technology and Research Trust
Member, Board of Trustees
—
Also at STERIS plc
Related
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.